These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31565884)

  • 1. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas.
    Kim YH; Kim JH
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):314-322. PubMed ID: 31565884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
    Gu YH; Feng YG
    J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
    Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in CD8
    Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
    Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas.
    Hong L; Wu Y; Feng J; Yu S; Li C; Wu Y; Li Z; Cao L; Wang F; Zhang Y
    Hum Pathol; 2014 Dec; 45(12):2423-9. PubMed ID: 25281028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
    Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
    Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas.
    Liu C; Li Z; Wu D; Li C; Zhang Y
    Onco Targets Ther; 2016; 9():2265-71. PubMed ID: 27143922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
    Joshi H; Vastrad B; Vastrad C
    J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of competitive endogenous ribose nucleic acids (ceRNAs)-related regulatory networks in invasive and non-invasive non-functioning pituitary adenomas (NFPAs).
    Liu J; Wang K; Ji H; Zhang G; Chen S; Zhang S; Lu F; Hu C
    Front Surg; 2022; 9():983958. PubMed ID: 36248377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
    Liu D; Li J; Li N; Lu M; Wen S; Zhan X
    EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas.
    Lin K; Zhang J; Lin Y; Pei Z; Wang S
    Front Endocrinol (Lausanne); 2022; 13():901884. PubMed ID: 35898456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
    Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
    World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of differential gene expression by bead-based fiber-optic array in nonfunctioning pituitary adenomas.
    Jiang Z; Gui S; Zhang Y
    Horm Metab Res; 2011 May; 43(5):325-30. PubMed ID: 21351040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
    Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
    EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.
    Zhan X; Desiderio DM; Wang X; Zhan X; Guo T; Li M; Peng F; Chen X; Yang H; Zhang P; Li X; Chen Z
    Electrophoresis; 2014 Aug; 35(15):2184-94. PubMed ID: 24729304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.